Home › NDC Lookup › RxCUI directory › RxCUI 2632863

Trofinetide 200 MG/ML Oral Solution [Daybue] — RxCUI 2632863

RxNorm drug concept · Semantic branded drug
RxCUI 2632863 Semantic branded drug · SBD ● Current RxNorm concept 4 FDA products 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2632863
Official nameTrofinetide 200 MG/ML Oral Solution [Daybue]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asDaybue 200 MG/ML Oral Solution
FDA products mapped4
Package NDCs mapped4
Reported Medicaid activity (SDUD)4,625 prescriptions · 32 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Trofinetide: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Trofinetide — sold as Daybue and Daybue Stix — is used to treat Rett syndrome in adults and children who are at least 2 years old. Rett syndrome is a rare neurological condition, a...
  • You take it twice a day — once in the morning and once in the evening. The good news is it can be taken with or without food, so you don't need to time it around meals. It comes as...
  • How do I take it, and does it matter if I take it with food?
  • Daybue Stix is a powder you dissolve in water or another water-based drink (like juice, tea, or lemonade) right before giving it. You stir it until it's fully dissolved and then gi...
📖 Read our full Trofinetide guide →

🕸️ Concept Web — How Trofinetide 200 MG/ML Oral Solution [Daybue] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Trofinetide 200 MG/ML Oral Solution [Daybue] RxCUI 2632863

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Trofinetide 2632852
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Daybue 2632858
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Trofinetide Oral Solution 2632856
    • Trofinetide Oral Liquid Product 2632855
    • Trofinetide Oral Product 2632854
    • Trofinetide Oral Solution [Daybue] 2632862
    • Daybue Oral Liquid Product 2632861
    • Daybue Oral Product 2632860
    • Oral Solution 316968
    • Oral Liquid Product 1151137
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Trofinetide 200 MG/ML Oral Solution SCD · 2632857
  • Trofinetide 200 MG/ML SCDC · 2632853
  • Trofinetide Oral Solution SCDF · 2632856
  • Trofinetide Oral Liquid Product SCDG · 2632855
  • Trofinetide Oral Product SCDG · 2632854

Brand-Name Concepts

  • Trofinetide 200 MG/ML [Daybue] SBDC · 2632859
  • Trofinetide Oral Solution [Daybue] SBDF · 2632862
  • Daybue Oral Liquid Product SBDG · 2632861
  • Daybue Oral Product SBDG · 2632860
  • Daybue BN · 2632858

📦 FDA Products & Package NDCs

4 products · 4 package NDCs
4 package NDCs map to RxCUI 2632863 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
63090-0660-01 1 BOTTLE, PLASTIC in 1 CARTON (63090-660-01) / 450 mL in 1... Daybue Acadia Pharmaceuticals Inc. 2023-03-10
63090-0663-60 60 PACKET in 1 CARTON (63090-663-60) / 1 FOR SOLUTION in 1... Daybue Stix Acadia Pharmaceuticals Inc. 2025-12-11
63090-0664-60 60 PACKET in 1 CARTON (63090-664-60) / 1 FOR SOLUTION in 1... Daybue Stix Acadia Pharmaceuticals Inc. 2025-12-11
63090-0665-60 60 PACKET in 1 CARTON (63090-665-60) / 1 FOR SOLUTION in 1... Daybue Stix Acadia Pharmaceuticals Inc. 2025-12-11
Observed labelers: Acadia Pharmaceuticals Inc. (4) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.